Literature DB >> 2776583

Pharmacokinetics of intravenous terbutaline in asthmatic children.

C Hultquist1, C Lindberg, L Nyberg, B Kjellman, G Wettrell.   

Abstract

Seven asthmatic children were given terbutaline intravenously. The intact drug was measured in plasma and urine, and its conjugates were measured in urine. The decreasing plasma concentrations of terbutaline did not attain a terminal slope until 8-12 h after dosing. This was most likely due to different kinetics of the enantiomers. The terminal half-life was 8.8-15.8 h. Body clearance was 2.73-5.44 ml/min/kg, two-thirds of which were of renal origin. The volume of distribution (Vss) was 1.28-1.83 l/kg. The disposition pharmacokinetics of terbutaline do not rationalize a higher dose per kg body weight in children than in adults.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776583     DOI: 10.1159/000457576

Source DB:  PubMed          Journal:  Dev Pharmacol Ther        ISSN: 0379-8305


  4 in total

1.  Investigation of distribution and elimination of terbutaline sulfate in the perfused rat liver preparation.

Authors:  Selma Sahin; Yasemin Karabey
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

2.  Terbutaline pharmacokinetics in cows: preliminary data.

Authors:  Melanie J Boileau; Kevin E Washburn; Cyril R Clarke; Robert N Streeter; Lara K Maxwell
Journal:  Can J Vet Res       Date:  2007-01       Impact factor: 1.310

3.  Pharmacokinetics of bambuterol during oral administration to asthmatic children.

Authors:  H Ahlström; J Alvero; R Alvero; R Espos; L Fajutrao; J Herrera; B Kjellman; J Kubista; C Leviste; P Meyer; G Oldaeus; A Siricururat; P Vichyanond; G Wettrell; E Wong; L Laxmyr; L Nyberg; H Olsson; E Weibull; J Rosenborg
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics of terbutaline in humans: a systematic review.

Authors:  Khadeeja Sultan; Ammara Zamir; Waseem Ashraf; Imran Imran; Hamid Saeed; Anees Ur Rehman; Abdul Majeed; Muhammad Fawad Rasool
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-13       Impact factor: 3.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.